Conventional and nuclear medicine imaging in Ectopic Cushing's syndrome: A systematic review
- Creators
- Isidori, Andrea M
- Sbardella, Emilia
- Zatelli, Maria Chiara
- BOSCHETTI, MARA
- VITALE, GIOVANNI
- Colao, Annamaria
- Pivonello, Rosario
- ABC Study Group: Albiger N
- Ambrogio A
- Arnaldi G
- Arvat E
- Berardelli R
- Boscaro M
- Boschetti M
- Cannavò S
- Cavagnini F
- Colao A
- Corsello S
- Cozzolino A
- De Leo M
- Di Somma C
- Esposito K
- FERONE, DIEGO
- Foresta C
- GATTO, FEDERICO
- Giordano C
- Giugliano D
- Graziadio C
- Isidori A
- Loli P
- Manetti L
- Mannelli M
- Marzullo P
- Mantero F
- Minuto F
- Paragliola R
- Pecori Giraldi F
- Pivonello R
- Reimondo G
- Scaroni C
- Scillitani A
- Simeoli C
- Stigliano A
- Terzolo M
- Tortora F
- Trementino L
- Vitale G
- Zatelli M.
- Others:
- Isidori, Andrea M
- Sbardella, Emilia
- Zatelli, Maria Chiara
- Boschetti, Mara
- Vitale, Giovanni
- Colao, Annamaria
- Pivonello, Rosario
- ABC Study Group: Albiger, N
- Ambrogio, A
- Arnaldi, G
- Arvat, E
- Berardelli, R
- Boscaro, M
- Boschetti, M
- Cannavò, S
- Cavagnini, F
- Colao, A
- Corsello, S
- Cozzolino, A
- De Leo, M
- Di Somma, C
- Esposito, K
- Ferone, Diego
- Foresta, C
- Gatto, Federico
- Giordano, C
- Giugliano, D
- Graziadio, C
- Isidori, A
- Loli, P
- Manetti, L
- Mannelli, M
- Marzullo, P
- Mantero, F
- Minuto, F
- Paragliola, R
- Pecori Giraldi, F
- Pivonello, R
- Reimondo, G
- Scaroni, C
- Scillitani, A
- Simeoli, C
- Stigliano, A
- Terzolo, M
- Tortora, F
- Trementino, L
- Vitale, G
- Zatelli, M.
Description
Context: Ectopic Cushing's Syndrome (ECS) can be a diagnostic challenge with the hormonal source difficult to find. This study analyzes the accuracy of imaging studies in ECS localization. EvidenceAcquisition:SystematicreviewofmedicalliteratureforECScaseseriesprovidingindividualpatient data on at least one conventional imaging technique (computed tomography [CT]/magnetic resonance imaging) and one of the following: 111In-pentetreotide (OCT), 131I/123I-metaiodobenzylguanidine, 18Ffluoro-2-deoxyglucose-positron emission tomography (FDG-PET), 18F-fluorodopa-PET (F-DOPA-PET), 68Ga-DOTATATE-PET/CT or 68Ga-DOTATOC-PET/CT scan (68Gallium-SSTR-PET/CT). Evidence Summary: The analysis comprised 231 patients (females, 50.2%; age, 42.6±17 y). Overall, 52.4%(121/231)had"overt" ECS,18.6%had"occult" ECS,and29%had"covert" ECS. Tumors were located in the lung (55.3%), mediastinum-thymus (7.9%), pancreas (8.5%), adrenal glands (6.4%), gastrointestinal tract (5.4%), thyroid (3.7%), and other sites (12.8%), and primary tumors were mostly bronchial neuroendocrine tumors (NETs) (54.8%), pancreatic NETs (8%), mediastinum-thymusNETs (6.9%), gastrointestinal NETs (5.3%), pheochromocytoma (6.4%), neuroblastoma (3.2%), andmedullary thyroid carcinoma (3.2%).Tumorswerelocalized byCTin66.2%(137/207), magnetic resonance imaging in 51.5% (53/103), OCT in 48.9% (84/172), FDG-PET in 51.7% (46/89), F-DOPAPET in 57.1% (12/21), 131/123II-metaiodobenzylguanidine in 30.8% (4/13), and 68Gallium-SSTRPET/ CT in 81.8% (18/22) of cases. Molecular imaging discovered 79.1% (53/67) of tumors unidentified by conventional radiology, with OCT the most commonly used, revealing the tumor in 64%, followed by FDG-PET in 59.4%. F-DOPA-PET was used in only seven covert cases (sensitivity, 85.7%). Notably, 68Gallium-SSTR-PET/CT had 100% sensitivity among covert cases. Conclusions: Nuclear medicine improves the sensitivity of conventional radiology when tumor site identification is problematic. OCT offers a good availability/reliability ratio, and FDG-PET was proven useful. 68Gallium-SSTR-PET/CT use was infrequent, despite offering the highest sensitivity.
Additional details
- URL
- http://hdl.handle.net/11567/862071
- URN
- urn:oai:iris.unige.it:11567/862071
- Origin repository
- UNIGE